Jodi Wu - Partner


PDF Print Friendly Page
Jodi Wu

Download V-Card

Phone: +8621-3857-6337
Fax: +8621-3857-6301
Overview News Publications

Professional Profile

To view Jodi Wu’s profile in simplified Chinese characters, please click here.

Jodi concentrates her practice in the areas of government enforcement and internal investigations and cross-border litigation. Jodi has advised both public and private multinational corporations on complex legal issues involving both U.S. and Chinese law.

In China, Jodi has advised numerous multi-national companies with regard to legal and compliance issues arising from their business in Asia, including issues relating to cross-border litigation, anti-corruption (including the Foreign Corrupt Practices Act), antitrust, and data privacy and cyber security.

In the U.S., Jodi has defended corporations and individuals in government investigations and other criminal and regulatory proceedings in connection with the FCPA, the False Claims Act, U.S. securities laws, and complex litigation matters. Jodi was featured in the Global Investigations Review’s “Women in Investigations 2015” series.

Representative Matters

Government Investigation & Internal Investigation Matters

  • Conducted internal investigations and represented pharmaceutical and medical device companies in FCPA investigations conducted by the U.S. Department of Justice (DOJ), the U.S. Securities and Exchange Commission (SEC), and Chinese authorities, including the Administration of Industry and Commerce (AIC), the State Food and Drug Administration (SFDA), and the Ministry of Public Security (MPS/PSB).

  • Represented a China-based agricultural company in an FCPA investigation by the SEC.

  • Served as part of the independent investigator team appointed pursuant to a negotiated resolution agreement between the World Bank Group and a major multinational corporation with operations in over 100 countries.

  • Counsel for an energy drink manufacturer in an investigation and hearings before the U.S. Senate Committee on Commerce, Science and Transportation into the sales and marketing practices of the energy drink industry.

  • Represented a major gaming industry client in an FCPA and anti-money laundering investigation conducted by the DOJ.

  • Represented the former CEO of that largest publicly traded Real Estate Investment Trust (REIT) in an investigation conducted by the SEC involving the alleged accounting fraud and material misstatements.

  • Represented the former tax manager of a multinational corporation in an investigation conducted by the SEC involving a $400 million restatement and allegations of securities laws violations.

Litigation Matters

  • Represented publicly-listed Chinese companies, including a major tool manufacturer and international shipping company, in litigation matters in the U.S.

  • Represented pharmaceutical, biotechnology, and medical device companies and other healthcare institutions, providers, and executives in healthcare fraud investigations conducted by federal and state enforcement agencies involving allegations of off-label promotion, improper sales and marketing practices, pricing issues, and alleged violations of the Anti-Kickback Statute and False Claims Act.

  • Trial counsel for Houston Astros in multiple trials concerning the involuntary bankruptcy commenced against the Houston Regional Sports Network, a partnership between the Astros, Comcast, and the Houston Rockets.

  • Trial counsel for plaintiffs challenging voting restrictions in North Carolina.


Co-author, “Heads or Tails? Are Europe’s GDPR and China’s Cybersecurity Law Two Sides of the Same Coin?” China Business Law Journal, 25 May 2018

“Challenges and Advice for Multinational Companies in Complying With Chinese Cybersecurity Law,” New York Law Journal, 23 February 2018

“China’s Second Draft Cybersecurity Law’s Expands Data Localization Requirement,” Legaltech News, 19 September 2016


U.S. District Court for the District of Maryland

U.S. Court of Appeals for the Fourth Circuit

© 2018 Kirkland & Ellis LLP